News Chan Zuckerberg Initiative to put $250M into new NYC Biohub The Chan Zuckerberg Initiative's new NYC Biohub will develop new bio-engineered immune cells that can aide in early detection of diseases.
Views & Analysis Digital Health Round-up: an artificial future for diabetes A round-up of this week's digital healthcare news. Marco Ricci reports.
Views & Analysis Digital Health Round-up - Trump's reign begins A round-up of this week's digital healthcare news. Marco Ricci reports.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends